View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
March 4, 2010

OmniComm Unveils TrialOne For Phase I Clinical Automation, Management

OmniComm Systems (OmniComm), a provider of eClinical solutions, has released a fully integrated, MS .NET, web-based solution TrialOne to automate the Phase I clinical trial process.

By CBR Staff Writer

OmniComm claimed that TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and address the unique requirements of early phase studies.

Within each study, real-time electronic data is captured and validated directly at the subject’s bedside or at a subject queuing station. Enhanced workflow technology automates sample processing throughout the lab.

Additionally, TrialOne supports a myriad of directly attached biomedical monitoring devices such as the GE Healthcare Dinamap family of vital signs monitors and various ECG devices.

TrialOne enables Phase I Clinics to share data directly with other stakeholders via the internet and provides a flexible ad-hoc reporting tool to help export and report data in various formats including Adobe PDF, Microsoft Excel and Word. Further extensibility of the TrialOne suite via integration to our flagship EDC product, TrialMaster, using OmniConnect, our enhanced web services API, and an integrated pharmacy module is planned for release later this year.

Content from our partners
Unlocking growth through hybrid cloud: 5 key takeaways
How businesses can safeguard themselves on the cyber frontline
How hackers’ tactics are evolving in an increasingly complex landscape

Randy Smith, CTO of OmniComm, said: TrialOne is the only available product that handles all aspects of the Phase I process from subject recruitment and clinical workflow management to laboratory sample management.

Other EDC solutions used in later stage trials do not include a proactive data collection system, which is imperative for the very time sensitive data collection processes inherent to early stage clinical studies.

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.